Vanguard amends Schedule 13G for Joint Corp/The (JYNT) after internal realignment
Filing Impact
Filing Sentiment
Form Type
SCHEDULE 13G/A
Rhea-AI Filing Summary
The Vanguard Group filed Amendment No. 3 to a Schedule 13G for Joint Corp/The reporting that, after an internal realignment, its filing shows 0 shares beneficially owned and 0% of the class. The amendment cites the January 12, 2026 realignment and SEC Release No. 34-39538 to explain that certain Vanguard subsidiaries will report ownership separately.
The filing lists the issuer as Joint Corp/The (principal executive offices at 16767 N Perimeter Dr, Suite 110, Scottsdale, AZ) and is signed by Ashley Grim, Head of Global Fund Administration, on 03/27/2026.
Positive
- None.
Negative
- None.
FAQ
What does The Vanguard Group report in the JYNT Schedule 13G/A amendment?
The amendment reports 0 shares beneficially owned and 0% of Joint Corp/The common stock. It explains an internal realignment on January 12, 2026 that led to separate reporting by certain Vanguard subsidiaries.
Why did Vanguard file Amendment No. 3 to the Schedule 13G for JYNT?
Vanguard amended to disclose an internal realignment effective January 12, 2026. In reliance on SEC Release No. 34-39538, certain subsidiaries now report beneficial ownership separately from The Vanguard Group, Inc.
Who signed the Schedule 13G/A amendment for JYNT and when was it signed?
The amendment is signed by Ashley Grim, Head of Global Fund Administration, with a signature date of 03/27/2026, attesting to the reported ownership and disclosures in the filing.
What issuer details are provided in the JYNT Schedule 13G/A amendment?
The filing identifies the issuer as Joint Corp/The with principal executive offices at 16767 N Perimeter Dr, Suite 110, Scottsdale, AZ, 85260, and lists the class as Common Stock.